Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
08-10 October, 2025
Pharma MES 2025Pharma MES 2025
Not Confirmed
Not Confirmed
10-11 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
08-10 October, 2025
Pharma MES 2025Pharma MES 2025
Industry Trade Show
Not Confirmed
10-11 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-bridge-the-gap-between-chemistry-and-performance-to-deliver-precise-optimized-micronization-for-complex-apis
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
30 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nls-pharmaceutics-shareholders-approve-merger-with-kadimastem-and-related-proposals-at-extraordinary-general-meeting-302570495.html
10 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/kadimastem-and-nls-pharmaceutics-announce-effectiveness-of-sec-registration-statement-in-connection-with-proposed-merger-302552188.html
04 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nls-pharmaceutics-and-kadimastem-announce-a-hong-kong-patent-covering-cell-selection-and-enrichment-technology-for-isletrx-for-diabetes-patients-302546486.html
17 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nls-pharmaceutics-highlights-continued-progress-in-itol-102-diabetes-program-as-bird-foundation-approves-additional-milestone-payment-to-kadimastem-and-itolerance-for-continued-co-development-of-type-1-diabetes-cell-therapy-302507798.html
30 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nls-pharmaceutics-and-kadimastem-announce-pricing-and-closing-of-1-million-equity-financing-302494234.html
21 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nls-pharmaceutics-to-present-new-data-on-the-dual-efficacy-of-mazindol-er-in-fentanyl-reward-and-withdrawal-at-the-2025-ascp-annual-meeting-302461603.html
ABOUT THIS PAGE